vs

Side-by-side financial comparison of Lakeside Holding Ltd (LSH) and Valaris Ltd (VAL). Click either name above to swap in a different company.

Lakeside Holding Ltd is the larger business by last-quarter revenue ($7.0M vs $5.2M, roughly 1.3× Valaris Ltd). Valaris Ltd runs the higher net margin — 13798.1% vs -22.6%, a 13820.7% gap on every dollar of revenue. On growth, Valaris Ltd posted the faster year-over-year revenue change (405.9% vs 95.0%).

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.

LSH vs VAL — Head-to-Head

Bigger by revenue
LSH
LSH
1.3× larger
LSH
$7.0M
$5.2M
VAL
Growing faster (revenue YoY)
VAL
VAL
+310.8% gap
VAL
405.9%
95.0%
LSH
Higher net margin
VAL
VAL
13820.7% more per $
VAL
13798.1%
-22.6%
LSH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LSH
LSH
VAL
VAL
Revenue
$7.0M
$5.2M
Net Profit
$-1.6M
$717.5M
Gross Margin
27.2%
-7850.0%
Operating Margin
-21.3%
Net Margin
-22.6%
13798.1%
Revenue YoY
95.0%
405.9%
Net Profit YoY
18.7%
436.6%
EPS (diluted)
$-0.08
$10.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSH
LSH
VAL
VAL
Q4 25
$7.0M
$5.2M
Q3 25
$6.1M
$5.6M
Q2 25
$6.3M
$700.0K
Q1 25
$3.8M
Q4 24
$3.6M
$-1.7M
Q3 24
$4.1M
$3.9M
Q2 24
$4.8M
Q1 24
$2.6M
Net Profit
LSH
LSH
VAL
VAL
Q4 25
$-1.6M
$717.5M
Q3 25
$-1.4M
$188.1M
Q2 25
$-893.1K
$115.1M
Q1 25
$-1.1M
Q4 24
$-1.9M
$133.7M
Q3 24
$-1.3M
$64.6M
Q2 24
$149.6M
Q1 24
$25.5M
Gross Margin
LSH
LSH
VAL
VAL
Q4 25
27.2%
-7850.0%
Q3 25
18.2%
-7142.9%
Q2 25
26.7%
-56428.6%
Q1 25
18.8%
Q4 24
-1.2%
24529.4%
Q3 24
12.8%
-11748.7%
Q2 24
-9039.6%
Q1 24
-17007.7%
Operating Margin
LSH
LSH
VAL
VAL
Q4 25
-21.3%
Q3 25
-20.8%
Q2 25
-8.9%
Q1 25
-28.2%
Q4 24
-55.6%
Q3 24
-32.5%
Q2 24
Q1 24
Net Margin
LSH
LSH
VAL
VAL
Q4 25
-22.6%
13798.1%
Q3 25
-22.2%
3358.9%
Q2 25
-14.2%
16442.9%
Q1 25
-28.2%
Q4 24
-54.1%
-7864.7%
Q3 24
-32.7%
1656.4%
Q2 24
3116.7%
Q1 24
980.8%
EPS (diluted)
LSH
LSH
VAL
VAL
Q4 25
$-0.08
$10.13
Q3 25
$-0.09
$2.65
Q2 25
$-0.11
$1.61
Q1 25
$-0.14
Q4 24
$-0.26
$1.86
Q3 24
$-0.18
$0.88
Q2 24
$2.03
Q1 24
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSH
LSH
VAL
VAL
Cash + ST InvestmentsLiquidity on hand
$1.6M
$599.4M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$12.2M
$3.2B
Total Assets
$24.3M
$5.3B
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSH
LSH
VAL
VAL
Q4 25
$1.6M
$599.4M
Q3 25
$4.5M
$662.7M
Q2 25
$5.0M
$503.4M
Q1 25
$1.5M
Q4 24
$1.1M
$368.2M
Q3 24
$2.7M
$379.3M
Q2 24
$398.3M
Q1 24
$494.1M
Total Debt
LSH
LSH
VAL
VAL
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
LSH
LSH
VAL
VAL
Q4 25
$12.2M
$3.2B
Q3 25
$7.0M
$2.4B
Q2 25
$2.8M
$2.3B
Q1 25
$749.8K
Q4 24
$1.6M
$2.2B
Q3 24
$3.6M
$2.1B
Q2 24
$2.2B
Q1 24
$2.0B
Total Assets
LSH
LSH
VAL
VAL
Q4 25
$24.3M
$5.3B
Q3 25
$18.6M
$4.6B
Q2 25
$14.4M
$4.5B
Q1 25
$9.9M
Q4 24
$9.8M
$4.4B
Q3 24
$10.8M
$4.3B
Q2 24
$4.4B
Q1 24
$4.4B
Debt / Equity
LSH
LSH
VAL
VAL
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSH
LSH
VAL
VAL
Operating Cash FlowLast quarter
$-453.5K
$72.2M
Free Cash FlowOCF − Capex
$-34.1M
FCF MarginFCF / Revenue
-655.8%
Capex IntensityCapex / Revenue
2044.2%
Cash ConversionOCF / Net Profit
0.10×
TTM Free Cash FlowTrailing 4 quarters
$159.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSH
LSH
VAL
VAL
Q4 25
$-453.5K
$72.2M
Q3 25
$-4.0M
$198.1M
Q2 25
$-483.7K
$120.0M
Q1 25
$-238.3K
Q4 24
$-530.2K
$124.6M
Q3 24
$-1.4M
$193.0M
Q2 24
$11.5M
Q1 24
$26.3M
Free Cash Flow
LSH
LSH
VAL
VAL
Q4 25
$-34.1M
Q3 25
$128.3M
Q2 25
$-497.4K
$52.8M
Q1 25
Q4 24
$-560.5K
$12.9M
Q3 24
$-1.4M
$111.1M
Q2 24
$-98.7M
Q1 24
$-125.0M
FCF Margin
LSH
LSH
VAL
VAL
Q4 25
-655.8%
Q3 25
2291.1%
Q2 25
-7.9%
7542.9%
Q1 25
Q4 24
-15.6%
-758.8%
Q3 24
-34.5%
2848.7%
Q2 24
-2056.3%
Q1 24
-4807.7%
Capex Intensity
LSH
LSH
VAL
VAL
Q4 25
2044.2%
Q3 25
1246.4%
Q2 25
0.2%
9600.0%
Q1 25
0.0%
Q4 24
0.8%
-6570.6%
Q3 24
0.1%
2100.0%
Q2 24
2295.8%
Q1 24
5819.2%
Cash Conversion
LSH
LSH
VAL
VAL
Q4 25
0.10×
Q3 25
1.05×
Q2 25
1.04×
Q1 25
Q4 24
0.93×
Q3 24
2.99×
Q2 24
0.08×
Q1 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

VAL
VAL

Segment breakdown not available.

Related Comparisons